Accendra Health, Inc. (ACH) — Financial statements
Income statement, balance sheet, and cash flow for Accendra Health, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 2,762↓74.2% | 10,701↑3.6% | 10,334↑3.8% | 9,955↑1.7% | 9,785 | |
| Cost of Revenue | 1,560↓81.6% | 8,482↑3.3% | 8,209↑1.0% | 8,129↓1.7% | 8,272 | |
| Gross Profit | 1,202↓45.9% | 2,219↑4.4% | 2,125↑16.4% | 1,826↑20.7% | 1,513 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00↓100.0% | 12 | |
| General & Administrative Expenses | 0.00↓100.0% | 1,910 | 0.00 | 0.00 | 0.00 | |
| Selling & Marketing Expenses | 0.00↓100.0% | 0.02↑1.7% | 0.02↑6.9% | 0.02↑43.8% | 0.01 | |
| SG&A Expenses | 1,054↓44.8% | 1,910↑5.3% | 1,814↑16.6% | 1,555↑44.4% | 1,077 | |
| Other Expenses | -2↓100.5% | 517↑149.7% | 207↑61.0% | 129↑131.4% | 56 | |
| Operating Expenses | 1,051↓56.7% | 2,427↑20.1% | 2,021↑20.0% | 1,683↑47.1% | 1,145 | |
| Total Costs & Expenses | 2,612↓76.1% | 10,909↑6.6% | 10,229↑4.2% | 9,813↑4.2% | 9,417 | |
| Operating Results | ||||||
| Operating Income | 150↑172.3% | -208↓298.8% | 105↓26.9% | 143↓61.2% | 368 | |
| Depreciation & Amortization | 215↓19.0% | 265↓7.9% | 287↑25.7% | 229↑152.3% | 91 | |
| EBITDA | 365↑612.0% | 51↓86.9% | 391↑6.0% | 368↓11.3% | 415 | |
| EBIT | 150↑170.3% | -214↓307.0% | 103↓26.2% | 140↓57.0% | 325 | |
| Interest & Other Income | ||||||
| Net Interest Income | -129↑10.2% | -144↑8.9% | -158↓22.5% | -129↓168.0% | -48 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 129↓10.2% | 144↓8.9% | 158↑22.5% | 129↑168.0% | 48 | |
| Non-Operating Income | 0.00↓100.0% | 6↑338.5% | 1↓57.9% | 3↓92.8% | 44 | |
| Other Income / Expenses | -252↓68.5% | -150↑6.1% | -159↓20.6% | -132↓43.9% | -92 | |
| Income Before Tax | -102↑71.5% | -357↓553.0% | -55↓602.5% | 11↓96.1% | 277 | |
| Income Tax Expense | 0.73↓86.3% | 5↑139.7% | -13↓16.8% | -11↓120.8% | 55 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -103↑71.7% | -363↓778.2% | -41↓284.5% | 22↓89.9% | 222 | |
| Net Income from Discontinued Operations | -998 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -1,101↓203.5% | -363↓778.2% | -41↓284.5% | 22↓89.9% | 222 | |
| Bottom-Line Net Income | -1,101↓203.5% | -363↓778.2% | -41↓284.5% | 22↓89.9% | 222 | |
| EPS (Basic) | -14.31↓202.5% | -4.73↓775.9% | -0.54↓280.0% | 0.30↓90.2% | 3.05 | |
| EPS (Diluted) | -14.31↓202.5% | -4.73↓775.9% | -0.54↓286.2% | 0.29↓90.1% | 2.94 | |
| Weighted Average Shares | 77↑0.2% | 77↑1.3% | 76↑1.7% | 74↑2.4% | 73 | |
| Weighted Average Diluted Shares | 77↑0.2% | 77↑1.3% | 76↓0.6% | 76↑1.0% | 75 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.